0.6497
price down icon30.02%   -0.2787
after-market After Hours: .65 0.0003 +0.05%
loading
Applied Dna Sciences Inc stock is traded at $0.6497, with a volume of 4.55M. It is down -30.02% in the last 24 hours and down -65.98% over the past month. Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
See More
Previous Close:
$0.9284
Open:
$0.91
24h Volume:
4.55M
Relative Volume:
0.48
Market Cap:
$6.69M
Revenue:
$9.00M
Net Income/Loss:
$-7.21M
P/E Ratio:
-1.3535
EPS:
-0.48
Net Cash Flow:
$-7.59M
1W Performance:
-42.50%
1M Performance:
-65.98%
6M Performance:
-92.08%
1Y Performance:
-97.32%
1-Day Range:
Value
$0.602
$0.91
1-Week Range:
Value
$0.602
$1.13
52-Week Range:
Value
$0.3131
$26.00

Applied Dna Sciences Inc Stock (APDN) Company Profile

Name
Name
Applied Dna Sciences Inc
Name
Phone
631-240-8800
Name
Address
50 HEALTH SCIENCES DRIVE, STONY BROOK, NY
Name
Employee
55
Name
Twitter
@APDN
Name
Next Earnings Date
2024-08-08
Name
Latest SEC Filings
Name
APDN's Discussions on Twitter

Applied Dna Sciences Inc Stock (APDN) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-12-21 Initiated ROTH Capital Buy
Jan-14-21 Reiterated H.C. Wainwright Buy
Dec-18-20 Reiterated H.C. Wainwright Buy
Jul-20-20 Reiterated H.C. Wainwright Buy
Jul-02-20 Initiated H.C. Wainwright Buy
Nov-14-16 Reiterated Maxim Group Buy
May-13-16 Reiterated Maxim Group Buy
Oct-08-15 Reiterated Maxim Group Buy
May-26-15 Initiated The Benchmark Company Speculative Buy
Feb-10-15 Reiterated Maxim Group Buy
Jan-13-15 Initiated Maxim Group Buy
View All

Applied Dna Sciences Inc Stock (APDN) Latest News

pulisher
02:17 AM

Applied DNA stock jumps amid U.S. government mpox update - MSN

02:17 AM
pulisher
Sep 23, 2024

Applied Materials Inc. [AMAT] Insider Activity: An Update for Investors - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

American Superconductor (NASDAQ:AMSC) Trading 4.2% Higher - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Applied Digital (NASDAQ:APLD) Stock Price Up 4.3% - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Research Analysts’ Price Target Changes for September 23rd (ADUS, AIT, AIZ, ALLY, AMRC, AMT, APLS, APVO, ASND, BA) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Market Watch: Applied Dna Sciences Inc (APDN)’s Noteworthy Gain, Closing at 1.25 - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

ADAP’s price-to-sales ratio: Is it a good investment opportunity? - US Post News

Sep 23, 2024
pulisher
Sep 23, 2024

Applied Digital Co. (NASDAQ:APLD) Stock Position Increased by Hood River Capital Management LLC - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Edge Capital Group LLC Reduces Position in Applied Materials, Inc. (NASDAQ:AMAT) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Ratios Uncovered: Breaking Down Adaptimmune Therapeutics Plc ADR (ADAP)’s Trailing Twelve Months Metrics - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Hood River Capital Management LLC Has $40.58 Million Stake in American Superconductor Co. (NASDAQ:AMSC) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Reasons for the Rise of Applied Materials (AMAT) in Q2 - Insider Monkey

Sep 23, 2024
pulisher
Sep 23, 2024

Applied Dna Sciences Inc (APDN) presents a great opportunity, but the stock is slightly overvalued - US Post News

Sep 23, 2024
pulisher
Sep 23, 2024

StockWatch: FDA Surprise Lifts Expectations for Applied’s Govorestat - Genetic Engineering & Biotechnology News

Sep 23, 2024
pulisher
Sep 23, 2024

For Applied Therapeutics Insiders, Selling US$8.5m Of Shares Was A Smart Move - Simply Wall St

Sep 23, 2024
pulisher
Sep 23, 2024

Up 6%, What's Next For Applied Materials Stock? - Forbes

Sep 23, 2024
pulisher
Sep 23, 2024

Rhumbline Advisers Purchases 44,888 Shares of American Superconductor Co. (NASDAQ:AMSC) - Defense World

Sep 23, 2024
pulisher
Sep 22, 2024

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement - Chronicle-Tribune

Sep 22, 2024
pulisher
Sep 20, 2024

Adma Biologics (ADMA) Gains As Market Dips: What You Should Know - Yahoo Finance

Sep 20, 2024
pulisher
Sep 19, 2024

Applied Digital (NASDAQ:APLD) Shares Down 2.8% - MarketBeat

Sep 19, 2024
pulisher
Sep 19, 2024

Why Applied Materials (AMAT) Stock Is Rising - Benzinga

Sep 19, 2024
pulisher
Sep 19, 2024

Applied Therapeutics: AdCom Decision Takes Govorestat Approval A Step Closer (NASDAQ:APLT) - Seeking Alpha

Sep 19, 2024
pulisher
Sep 19, 2024

Applied Therapeutics stock surges after FDA update - The Pharma Letter

Sep 19, 2024
pulisher
Sep 19, 2024

Argent Trust Co Purchases 2,682 Shares of Applied Materials, Inc. (NASDAQ:AMAT) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

CEO Gary Dickerson Says Applied Materials, Inc. (AMAT) Is Delivering Strong Results in 2024 - Insider Monkey

Sep 19, 2024
pulisher
Sep 19, 2024

Applied DNA regains Nasdaq compliance with bid price By Investing.com - Investing.com Canada

Sep 19, 2024
pulisher
Sep 18, 2024

Why Applied Therapeutics Stock Is Skyrocketing Today - sharewise

Sep 18, 2024
pulisher
Sep 18, 2024

Applied Digital Target of Unusually Large Options Trading (NASDAQ:APLD) - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Recent Insider Activity Could Benefit Adaptimmune Therapeutics Plc ADR (ADAP) - Knox Daily

Sep 18, 2024
pulisher
Sep 18, 2024

Applied Therapeutics (NASDAQ:APLT) Trading Down 4.1% - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Applied Digital Corporation (APLD) rating initates by ROTH MKM - Knox Daily

Sep 18, 2024
pulisher
Sep 18, 2024

ADMA Biologics stock soars to all-time high of $19.36 - Investing.com

Sep 18, 2024
pulisher
Sep 18, 2024

Applied Therapeutics Surges on Positive FDA Update for Govorestat - BP Journal

Sep 18, 2024
pulisher
Sep 18, 2024

Are Smart Investors Making the Right Decision? Applied Therapeutics Inc (APLT) - SETE News

Sep 18, 2024
pulisher
Sep 18, 2024

Applied Therapeutics: FDA Stance Change For Advisory Panel Bodes Well For Review (APLT) - Seeking Alpha

Sep 18, 2024
pulisher
Sep 18, 2024

Applied Digital (NASDAQ:APLD) Shares Gap Down to $6.09 - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Applied Therapeutics Inc (APLT) Stock: From Low to High in 52 Weeks - The InvestChronicle

Sep 18, 2024
pulisher
Sep 18, 2024

Stock Traders Purchase High Volume of Call Options on Applied Therapeutics (NASDAQ:APLT) - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

ADMA Biologics Stock Soars 76.2% in 3 Months: Right Time to Invest? - Zacks Investment Research

Sep 18, 2024
pulisher
Sep 18, 2024

Applied DNA Sciences regains compliance with Nasdaq minimum bid price rule - TipRanks

Sep 18, 2024
pulisher
Sep 18, 2024

APLT Soars After FDA Scraps Advisory Committee Meeting - GuruFocus.com

Sep 18, 2024
pulisher
Sep 18, 2024

ADMA Biologics Stock Soars 76.2% in 3 Months: Right Time to Invest? - Yahoo Finance

Sep 18, 2024
pulisher
Sep 18, 2024

Applied Digital Corp call volume above normal and directionally bullish - TipRanks

Sep 18, 2024
pulisher
Sep 18, 2024

ADMA Biologics (NASDAQ:ADMA) Reaches New 52-Week High at $19.42 - MarketBeat

Sep 18, 2024
pulisher
Sep 18, 2024

Why Applied Therapeutics Stock Is Skyrocketing Today - The Motley Fool

Sep 18, 2024
pulisher
Sep 18, 2024

Applied Therapeutics Stock Soars As FDA Scraps Panel Meeting For Its Inherited Metabolic Disorder Drug - Benzinga

Sep 18, 2024
pulisher
Sep 18, 2024

Applied DNA regains Nasdaq compliance with bid price - Investing.com

Sep 18, 2024
pulisher
Sep 18, 2024

Take off with Applied Digital Corporation (APLD): Get ready for trading - SETE News

Sep 18, 2024
pulisher
Sep 18, 2024

Applied Therapeutics jumps as US FDA cancels panel meeting for genetic disorder drug - XM

Sep 18, 2024
pulisher
Sep 18, 2024

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement - The Hastings Tribune

Sep 18, 2024
pulisher
Sep 18, 2024

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement - AccessWire

Sep 18, 2024

Applied Dna Sciences Inc Stock (APDN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
diagnostics_research LH
$223.48
price up icon 0.62%
$130.41
price up icon 0.22%
diagnostics_research WAT
$359.89
price up icon 0.72%
$287.31
price up icon 0.60%
diagnostics_research MTD
$1,499.70
price up icon 1.41%
$505.22
price down icon 1.28%
Cap:     |  Volume (24h):